Radiotherapy Market (External, Brachytherapy & Systemic Radiotherapy) to Grow at 6.2% CAGR to 2020

20 Jan, 2016, 07:30 ET from RnR Market Research

PUNE, India, January 20, 2016 /PRNewswire/ --

North America to hold largest radiotherapy market share, globally, with worldwide markets expected to grow at a CAGR of 6.2% between 2015 and 2020 according to this newly published research report available with RnRMarketResearch.com.

Complete report on global radiotherapy market spread across 177 pages, profiling 10 companies and supported with 91 tables and 48 figures is now available at http://www.rnrmarketresearch.com/radiotherapy-devices-market-by-technology-applications-products-2011-2016-market-report.html .

By product, application, and technology, the radiotherapy market is broadly segmented into external beam radiotherapy, internal radiotherapy/brachytherapy, and systemic radiation therapy. The external beam radiotherapy segment accounts for the largest share of the radiotherapy market in 2015, and is expected to grow at the highest rate.

Geographically, the report covers four major geographies, namely, North America, Europe, Asia-Pacific, and the Rest of the World. North America is expected to command the largest share of the global radiotherapy market in 2015, followed by Europe. Asia-Pacific radiotherapy market is poised to witness highest growth rate during the forecast period from 2015 to 2020 due to a number of factors including improving healthcare infrastructure and supportive government activities.

Market growth is majorly driven by the technological advancements in radiotherapy products, rise in number of geriatric population, increasing incidence of cancer cases across the globe, increasing symposiums driving investments in radiotherapy, and growing adoption of radiotherapy devices and procedures.

As of 2014, the global radiotherapy market was dominated by Varian Medical Systems, Inc. (U.S.), Elekta AB (Sweden), and Accuray Incorporated (U.S.), which together held a share of 84.5% of the overall radiotherapy market. New product launches& product enhancements; agreements, collaborations, partnerships, and contracts; geographic expansions; strategic acquisitions; and others (awareness campaigns and offering research fund & grants) are the major strategies adopted by most market players to achieve growth in the global radiotherapy market. Order a copy of  Radiotherapy Market by Technology (External (IGRT, IMRT, VMAT, & Stereotactic), Brachytherapy (LDR & HDR), & Systemic Radiotherapy), Product (Cyberknife, Gammaknife, Linac, Proton Beam), & Application (Prostate & Breast Cancer)) - Global Forecasts to 2020 research repot at http://www.rnrmarketresearch.com/contacts/purchase?rname=57638 .

From an insight perspective, this research report has focused on various levels of analysis -market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the radiotherapy market, high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, and competitive assessment) for strengthening their market share.

On a related note, another research report on Immunotherapy Drugs Market Global Forecast to 2020 says, the immunotherapy drugs market is estimated to grow at a CAGR of 12.8% to reach USD 73,529.2 Million by 2020. The checkpoint inhibitors, by type of drugs, are expected to witness the fastest growth during the forecast period. The immunotherapy drugs market, by geography, is classified into North America, Europe, Asia-Pacific, and Rest of the World. Amgen Inc., GlaxoSmithKline Plc, Merck & Co., Inc., Novartis International Ag and Roche Holding Ag. http://www.rnrmarketresearch.com/immunotherapy-drugs-market-by-type-of-drug-monoclonal-antibodies-interferon-alpha-interleukins-vaccines-therapeutic-vaccines-and-preventive-vaccines-checkpoint-inhibitors-epidemiology-regulatory-and-pipeline-analysis-global-f-market-report.html .

About Us:   

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Connect with Us:  

G+ / Google Plus: https://plus.google.com/104156468549256253075/posts

Twitter: https://twitter.com/RnRMR

Facebook: https://www.facebook.com/pages/RnR-Market-Research/413488545356345

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel:  +1-888-391-5441
sales@rnrmarketresearch.com


SOURCE RnR Market Research